Dengue Author: Suranjith L. Seneviratne, MD, DPhil, MRCP, FRCPath; Panduka Karunanayake, MD, MRCP; Bandula Wijesiriwardena, MD, FRCP, FCCP, FCMSA, FRACP, FACP
Editorial changes - 2009-11-13
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Diagnosis
  • Use history to help distinguish dengue from other febrile infectious diseases.
  • Look for physical exam findings that suggest a diagnosis of dengue.
  • Use laboratory testing to confirm the diagnosis of dengue.
  • Consider the broad range of febrile diseases common in the tropics in the differential diagnosis of dengue.
History and Physical Examination Elements for Dengue (table)
Laboratory and Other Studies for Dengue (table)
Differential Diagnosis of the Dengue Presentation (table)


Use history to help distinguish dengue from other febrile infectious diseases.C

  • Ask about:
    • Duration of symptoms
    • Fever
    • Chills
    • Sweats
    • Nausea
    • Vomiting
    • Rash
    • Lassitude
    • Headache
    • Retro-orbital pain
    • Myalgia
    • Arthralgia
    • Body aches
    • Hemorrhagic manifestations involving the skin, nose, mouth, or gastrointestinal tract
    • Recent travel history
  • Ask about symptoms that may be characteristic of but not necessarily specific for dengue:
    • Fever
    • Myalgia
    • Retro-orbital pain
  • Ask about symptoms that are usually not characteristic of dengue:
    • Productive cough
    • Profuse, watery diarrhea
    • Allergic phenomena
  • Obtain a detailed travel history, including:
    • Travel to areas where dengue is epidemic or where recent epidemics have occurred
    • Duration of visit
    • Type of lodging
    • Type of travel
    • Type of food and water ingested
    • Onset of symptoms in relation to leaving a dengue-endemic area (if more than 2 weeks has passed, then dengue is effectively ruled out)
    • Potential mosquito exposure and occurrence of insect bites
    • Mosquitoes seen in home, work, or recreation environments
    • Standing water around the home or workplace
    • Use of barrier methods (e.g., screens, long-sleeved shirts) and protective measures (e.g., DEET)
    • Illness in travel companions, which may indicate group exposure to pathogenic agents, such as enteric bacteria or schistosomes
    • Chemoprophylaxis regimes and stand-by antibiotics
    • Sexual activity
  • Ask about pretravel vaccinations:
    • Yellow fever
    • Salmonella typhi
    • Influenza
  • See table History and Physical Examination Elements for Dengue.
  • See table WHO Case Definitions for Dengue Fever, Dengue Hemorrhagic Fever, and Dengue Shock Syndrome.
Background | Back to top


Look for physical exam findings that suggest a diagnosis of dengue.C

Background | Back to top


Use laboratory testing to confirm the diagnosis of dengue.B

Background | Back to top


Consider the broad range of febrile diseases common in the tropics in the differential diagnosis of dengue.B

  • Focus on the elements of the history and physical exam that help to differentiate dengue from other febrile illnesses.
  • Consider the following in the differential diagnosis of dengue:
    • Viral diseases
      • Chikungunya virus
      • Yellow fever
      • Hantavirus
      • Measles
      • Rubella
      • Enteroviruses
      • Influenza
      • Hepatitis A, B
    • Bacterial diseases
      • Meningococcemia
      • Scarlet fever
      • Typhoid
      • Leptospirosis
      • Rickettsial diseases
    • Parasitic diseases
      • Malaria
      • Schistosomiasis
  • See table Differential Diagnosis of the Dengue Presentation.
Background | Back to top

FAQs
Bandula Wijesiriwardena, MD, FRCP, FCCP, FCMSA, FRACP, FACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Panduka Karunanayake, MD, MRCP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Suranjith L. Seneviratne, MD, DPhil, MRCP, FRCPath has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.